We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Outfront Media
OUT
$5.24B
| $832K | ﹤0.01% |
45,760
+4,529
| +11% | +$83.9K |
|
1052
Polaris
PII
$3.91B
| $830K | ﹤0.01% |
14,400
-2,800
| -16% | -$195K |
|
1053
International Bancshares
IBOC
$4.57B
| $828K | ﹤0.01% |
13,102
+1,200
| +10% | +$79.6K |
|
|
FOLD
1054
DELISTED
Amicus Therapeutics
FOLD
| $824K | ﹤0.01% |
87,441
| – | – |
|
|
HBI
1055
DELISTED
Hanesbrands
HBI
| $821K | ﹤0.01% |
100,853
-7,500
| -7% | -$59K |
|
1056
Intapp
INTA
$3.16B
| $820K | ﹤0.01% |
12,800
+6,900
| +117% | +$396K |
|
1057
International Paper
IP
$21.8B
| $820K | ﹤0.01% |
15,238
+869
| +6% | +$46.6K |
|
1058
J&J Snack Foods
JJSF
$1.7B
| $819K | ﹤0.01% |
5,279
| – | – |
|
1059
LivaNova
LIVN
$4.53B
| $817K | ﹤0.01% |
17,637
+1,900
| +12% | +$97.4K |
|
1060
Valley National Bancorp
VLY
$8.3B
| $817K | ﹤0.01% |
90,287
+7,200
| +9% | +$69.8K |
|
1061
Interparfums
IPAR
$3.7B
| $815K | ﹤0.01% |
6,200
| – | – |
|
1062
Impinj
PI
$5.46B
| $813K | ﹤0.01% |
5,600
-600
| -10% | -$114K |
|
1063
Warby Parker
WRBY
$3.2B
| $813K | ﹤0.01% |
33,573
+8,500
| +34% | +$174K |
|
1064
Full Truck Alliance
YMM
$9.2B
| $813K | ﹤0.01% |
75,100
| – | – |
|
1065
Liberty Global Class A
LBTYA
$3.58B
| $812K | ﹤0.01% |
+63,600
| New | +$1.06M |
|
|
WCN
1066
Waste Connections
WCN
$41.6B
| $812K | ﹤0.01% |
4,731
-398
| -8% | -$72.3K |
|
1067
Axos Financial
AX
$5.72B
| $810K | ﹤0.01% |
11,595
+1,600
| +16% | +$117K |
|
1068
Remitly
RELY
$5.39B
| $810K | ﹤0.01% |
35,900
| – | – |
|
1069
MSC Industrial Direct
MSM
$6.77B
| $809K | ﹤0.01% |
10,830
-1,000
| -8% | -$82.4K |
|
1070
Mueller Water Products
MWA
$3.98B
| $809K | ﹤0.01% |
35,936
| – | – |
|
1071
Diodes
DIOD
$4.48B
| $808K | ﹤0.01% |
13,109
| – | – |
|
1072
Hims & Hers Health
HIMS
$6.71B
| $808K | ﹤0.01% |
33,400
+6,600
| +25% | +$164K |
|
1073
PennyMac Financial
PFSI
$4.13B
| $807K | ﹤0.01% |
7,900
-500
| -6% | -$52.3K |
|
1074
Alight
ALIT
$394M
| $804K | ﹤0.01% |
5,810
-1,150
| -17% | -$169K |
|
1075
Korn Ferry
KFY
$4.36B
| $803K | ﹤0.01% |
11,902
+2,200
| +23% | +$160K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.